Higher serum dehydroepiandrosterone sulfate levels are protectively associated with depressive symptoms in men, but not in women

A community-based cohort study of older Japanese

Takehiro Michikawa, Yuji Nishiwaki, Makiko Nakano, Satoko Iwasawa, Mutsuko Yamada, Keiko Asakura, Noriyuki Yoshioka, Erika Kuwahara, Toru Takebayashi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: Dehydroepiandrosterone sulfate (DHEAS) appears to have a protective effect against depression, but evidence from prospective cohort studies is sparse. Therefore, weexamined the associationbetweenserumDHEAS levelsand depressive symptoms in older community-dwelling Japanese. Design: A community-based cohort study. Setting: Kurabuchi Town, Gunma Prefecture, Japan. Participants: A total of 554 residents (248 men and 306 women) age 65 years or older without depressive symptoms at baseline. Measurements: We performed a baseline examination of the subjects between 2005 and 2006 to determine serum DHEAS levels. The subjects were categorized into three groups based on age strata- and sex-specific tertiles of DHEAS. Depressive symptoms were assessed with the Geriatric Depression Scale 15-item version (GDS-15) in face-to-face home visit interviews carried out once in 2007 and once in 2008. The association of DHEAS with depressive symptoms (GDS-15 ≥ 6) was analyzed with the use of logistic regression models. Results: The incidence of depressive symptoms was 12.1% in men and 19.6% in women. In men, the multiadjusted odds ratio of depressive symptoms was 0.24 (95% confidence interval: 0.06-0.94, Wald χ2 = 4.20, degrees of freedom = 1, p = 0.04) for the highest tertile compared with the lowest. The association observed for the highest versus the lowest remained significant even after adjustment for physical performance and cognitive function. In women, DHEAS was not associated with depressive symptoms. Conclusions: In this study, higher serum DHEAS levels were found to be protectively and independently associated with the risk of developing depressive symptoms in men, but not in women.

Original languageEnglish
Pages (from-to)1154-1163
Number of pages10
JournalAmerican Journal of Geriatric Psychiatry
Volume21
Issue number11
DOIs
Publication statusPublished - 2013 Nov

Fingerprint

Dehydroepiandrosterone Sulfate
Cohort Studies
Depression
Serum
Geriatrics
Logistic Models
Independent Living
House Calls
Cognition
Japan
Odds Ratio
Prospective Studies
Confidence Intervals
Interviews

Keywords

  • Aged
  • Cohort
  • Dehydroepiandrosterone sulfate
  • Depression

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology

Cite this

Higher serum dehydroepiandrosterone sulfate levels are protectively associated with depressive symptoms in men, but not in women : A community-based cohort study of older Japanese. / Michikawa, Takehiro; Nishiwaki, Yuji; Nakano, Makiko; Iwasawa, Satoko; Yamada, Mutsuko; Asakura, Keiko; Yoshioka, Noriyuki; Kuwahara, Erika; Takebayashi, Toru.

In: American Journal of Geriatric Psychiatry, Vol. 21, No. 11, 11.2013, p. 1154-1163.

Research output: Contribution to journalArticle

Michikawa, Takehiro ; Nishiwaki, Yuji ; Nakano, Makiko ; Iwasawa, Satoko ; Yamada, Mutsuko ; Asakura, Keiko ; Yoshioka, Noriyuki ; Kuwahara, Erika ; Takebayashi, Toru. / Higher serum dehydroepiandrosterone sulfate levels are protectively associated with depressive symptoms in men, but not in women : A community-based cohort study of older Japanese. In: American Journal of Geriatric Psychiatry. 2013 ; Vol. 21, No. 11. pp. 1154-1163.
@article{095f700900ee49369d01fa14de03496d,
title = "Higher serum dehydroepiandrosterone sulfate levels are protectively associated with depressive symptoms in men, but not in women: A community-based cohort study of older Japanese",
abstract = "Objective: Dehydroepiandrosterone sulfate (DHEAS) appears to have a protective effect against depression, but evidence from prospective cohort studies is sparse. Therefore, weexamined the associationbetweenserumDHEAS levelsand depressive symptoms in older community-dwelling Japanese. Design: A community-based cohort study. Setting: Kurabuchi Town, Gunma Prefecture, Japan. Participants: A total of 554 residents (248 men and 306 women) age 65 years or older without depressive symptoms at baseline. Measurements: We performed a baseline examination of the subjects between 2005 and 2006 to determine serum DHEAS levels. The subjects were categorized into three groups based on age strata- and sex-specific tertiles of DHEAS. Depressive symptoms were assessed with the Geriatric Depression Scale 15-item version (GDS-15) in face-to-face home visit interviews carried out once in 2007 and once in 2008. The association of DHEAS with depressive symptoms (GDS-15 ≥ 6) was analyzed with the use of logistic regression models. Results: The incidence of depressive symptoms was 12.1{\%} in men and 19.6{\%} in women. In men, the multiadjusted odds ratio of depressive symptoms was 0.24 (95{\%} confidence interval: 0.06-0.94, Wald χ2 = 4.20, degrees of freedom = 1, p = 0.04) for the highest tertile compared with the lowest. The association observed for the highest versus the lowest remained significant even after adjustment for physical performance and cognitive function. In women, DHEAS was not associated with depressive symptoms. Conclusions: In this study, higher serum DHEAS levels were found to be protectively and independently associated with the risk of developing depressive symptoms in men, but not in women.",
keywords = "Aged, Cohort, Dehydroepiandrosterone sulfate, Depression",
author = "Takehiro Michikawa and Yuji Nishiwaki and Makiko Nakano and Satoko Iwasawa and Mutsuko Yamada and Keiko Asakura and Noriyuki Yoshioka and Erika Kuwahara and Toru Takebayashi",
year = "2013",
month = "11",
doi = "10.1016/j.jagp.2013.01.054",
language = "English",
volume = "21",
pages = "1154--1163",
journal = "American Journal of Geriatric Psychiatry",
issn = "1064-7481",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Higher serum dehydroepiandrosterone sulfate levels are protectively associated with depressive symptoms in men, but not in women

T2 - A community-based cohort study of older Japanese

AU - Michikawa, Takehiro

AU - Nishiwaki, Yuji

AU - Nakano, Makiko

AU - Iwasawa, Satoko

AU - Yamada, Mutsuko

AU - Asakura, Keiko

AU - Yoshioka, Noriyuki

AU - Kuwahara, Erika

AU - Takebayashi, Toru

PY - 2013/11

Y1 - 2013/11

N2 - Objective: Dehydroepiandrosterone sulfate (DHEAS) appears to have a protective effect against depression, but evidence from prospective cohort studies is sparse. Therefore, weexamined the associationbetweenserumDHEAS levelsand depressive symptoms in older community-dwelling Japanese. Design: A community-based cohort study. Setting: Kurabuchi Town, Gunma Prefecture, Japan. Participants: A total of 554 residents (248 men and 306 women) age 65 years or older without depressive symptoms at baseline. Measurements: We performed a baseline examination of the subjects between 2005 and 2006 to determine serum DHEAS levels. The subjects were categorized into three groups based on age strata- and sex-specific tertiles of DHEAS. Depressive symptoms were assessed with the Geriatric Depression Scale 15-item version (GDS-15) in face-to-face home visit interviews carried out once in 2007 and once in 2008. The association of DHEAS with depressive symptoms (GDS-15 ≥ 6) was analyzed with the use of logistic regression models. Results: The incidence of depressive symptoms was 12.1% in men and 19.6% in women. In men, the multiadjusted odds ratio of depressive symptoms was 0.24 (95% confidence interval: 0.06-0.94, Wald χ2 = 4.20, degrees of freedom = 1, p = 0.04) for the highest tertile compared with the lowest. The association observed for the highest versus the lowest remained significant even after adjustment for physical performance and cognitive function. In women, DHEAS was not associated with depressive symptoms. Conclusions: In this study, higher serum DHEAS levels were found to be protectively and independently associated with the risk of developing depressive symptoms in men, but not in women.

AB - Objective: Dehydroepiandrosterone sulfate (DHEAS) appears to have a protective effect against depression, but evidence from prospective cohort studies is sparse. Therefore, weexamined the associationbetweenserumDHEAS levelsand depressive symptoms in older community-dwelling Japanese. Design: A community-based cohort study. Setting: Kurabuchi Town, Gunma Prefecture, Japan. Participants: A total of 554 residents (248 men and 306 women) age 65 years or older without depressive symptoms at baseline. Measurements: We performed a baseline examination of the subjects between 2005 and 2006 to determine serum DHEAS levels. The subjects were categorized into three groups based on age strata- and sex-specific tertiles of DHEAS. Depressive symptoms were assessed with the Geriatric Depression Scale 15-item version (GDS-15) in face-to-face home visit interviews carried out once in 2007 and once in 2008. The association of DHEAS with depressive symptoms (GDS-15 ≥ 6) was analyzed with the use of logistic regression models. Results: The incidence of depressive symptoms was 12.1% in men and 19.6% in women. In men, the multiadjusted odds ratio of depressive symptoms was 0.24 (95% confidence interval: 0.06-0.94, Wald χ2 = 4.20, degrees of freedom = 1, p = 0.04) for the highest tertile compared with the lowest. The association observed for the highest versus the lowest remained significant even after adjustment for physical performance and cognitive function. In women, DHEAS was not associated with depressive symptoms. Conclusions: In this study, higher serum DHEAS levels were found to be protectively and independently associated with the risk of developing depressive symptoms in men, but not in women.

KW - Aged

KW - Cohort

KW - Dehydroepiandrosterone sulfate

KW - Depression

UR - http://www.scopus.com/inward/record.url?scp=84888642887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888642887&partnerID=8YFLogxK

U2 - 10.1016/j.jagp.2013.01.054

DO - 10.1016/j.jagp.2013.01.054

M3 - Article

VL - 21

SP - 1154

EP - 1163

JO - American Journal of Geriatric Psychiatry

JF - American Journal of Geriatric Psychiatry

SN - 1064-7481

IS - 11

ER -